Olink Holding AB IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Olink Holding AB | OLK - NASDAQ |
$16.00-$18.00 |
$20.00 |
$30.10 | 17.6 million | 3/25/2021 |
Goldman Sachs, Morgan Stanley, SVB Leerink |
Co-Manager(s): BTIG
|
Health Care |
Filing(s): Filed 2021-03-03 Terms Added 2021-03-18
|
For IPO Boutique's "scale of 1 to 5" BUY rating on Olink Holding AB, and our comprehensive analysis, click "Buy Market Research".
Olink Holding AB Quote & Chart - Click for current quote -
OLK
About Olink Holding AB (adapted from Olink Holding AB prospectus):
Their purpose is to enable and accelerate the field of proteomics by providing a platform of products and services, developed with key opinion leaders (KOLs), that are deployed across major pharmaceutical companies and leading clinical and academic institutions, to deepen the understanding of real-time human biology and drive 21st century healthcare through actionable and impactful science.
This description is adapted from prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as "OLK" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved